Annual Retained Earnings
-$480.50 M
-$13.32 M-2.85%
01 December 2023
Summary:
Plus Therapeutics annual retained earnings is currently -$480.50 million, with the most recent change of -$13.32 million (-2.85%) on 01 December 2023. During the last 3 years, it has fallen by -$46.99 million (-10.84%). PSTV annual retained earnings is now -2923.54% below its all-time high of -$15.89 million, reached on 31 December 2000.PSTV Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$489.58 M
-$2.87 M-0.59%
01 September 2024
Summary:
Plus Therapeutics quarterly retained earnings is currently -$489.58 million, with the most recent change of -$2.87 million (-0.59%) on 01 September 2024. Over the past year, it has dropped by -$9.07 million (-1.89%). PSTV quarterly retained earnings is now -2182.62% below its all-time high of -$21.45 million, reached on 30 June 2001.PSTV Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTV Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -1.9% |
| 3 y3 years | -10.8% | -10.6% |
| 5 y5 years | -16.0% | -14.9% |
PSTV Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -10.8% | at low | -10.6% | at low |
| 5 y | 5 years | -16.0% | at low | -15.1% | at low |
| alltime | all time | -2923.5% | at low | -2182.6% | at low |
Plus Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$489.58 M(+0.6%) |
| June 2024 | - | -$486.70 M(+0.6%) |
| Mar 2024 | - | -$483.76 M(+0.7%) |
| Dec 2023 | -$480.50 M(+2.9%) | -$480.50 M(+0.8%) |
| Sept 2023 | - | -$476.69 M(+0.7%) |
| June 2023 | - | -$473.47 M(+0.3%) |
| Mar 2023 | - | -$471.99 M(+1.0%) |
| Dec 2022 | -$467.19 M(+4.5%) | -$467.19 M(+1.2%) |
| Sept 2022 | - | -$461.53 M(+1.1%) |
| June 2022 | - | -$456.31 M(+1.2%) |
| Mar 2022 | - | -$451.03 M(+0.9%) |
| Dec 2021 | -$446.91 M(+3.1%) | -$446.91 M(+0.9%) |
| Sept 2021 | - | -$442.75 M(+0.8%) |
| June 2021 | - | -$439.03 M(+0.6%) |
| Mar 2021 | - | -$436.23 M(+0.6%) |
| Dec 2020 | -$433.51 M(+1.9%) | -$433.51 M(+0.8%) |
| Sept 2020 | - | -$429.92 M(+0.4%) |
| June 2020 | - | -$428.20 M(+0.4%) |
| Mar 2020 | - | -$426.36 M(+0.3%) |
| Dec 2019 | -$425.27 M(+2.6%) | -$425.27 M(-0.2%) |
| Sept 2019 | - | -$426.15 M(-0.1%) |
| June 2019 | - | -$426.68 M(+2.2%) |
| Mar 2019 | - | -$417.53 M(+0.8%) |
| Dec 2018 | -$414.38 M(+3.1%) | -$414.38 M(+0.5%) |
| Sept 2018 | - | -$412.15 M(+0.6%) |
| June 2018 | - | -$409.82 M(+0.9%) |
| Mar 2018 | - | -$406.16 M(+1.1%) |
| Dec 2017 | -$401.75 M(+6.0%) | -$401.75 M(+1.1%) |
| Sept 2017 | - | -$397.46 M(+1.2%) |
| June 2017 | - | -$392.66 M(+1.6%) |
| Mar 2017 | - | -$386.61 M(+2.0%) |
| Dec 2016 | -$379.06 M(+6.2%) | -$379.06 M(+1.3%) |
| Sept 2016 | - | -$374.14 M(+1.5%) |
| June 2016 | - | -$368.76 M(+1.8%) |
| Mar 2016 | - | -$362.36 M(+1.5%) |
| Dec 2015 | -$357.02 M(+5.5%) | -$357.02 M(+0.8%) |
| Sept 2015 | - | -$354.25 M(-0.4%) |
| June 2015 | - | -$355.78 M(-1.2%) |
| Mar 2015 | - | -$360.23 M(+6.5%) |
| Dec 2014 | -$338.27 M(+12.4%) | -$338.27 M(+1.7%) |
| Sept 2014 | - | -$332.52 M(+2.9%) |
| June 2014 | - | -$323.13 M(+3.8%) |
| Mar 2014 | - | -$311.31 M(+3.5%) |
| Dec 2013 | -$300.90 M(+9.5%) | -$300.90 M(+3.5%) |
| Sept 2013 | - | -$290.87 M(+1.8%) |
| June 2013 | - | -$285.61 M(+1.1%) |
| Mar 2013 | - | -$282.39 M(+2.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | -$274.73 M(+13.3%) | -$274.73 M(+1.4%) |
| Sept 2012 | - | -$270.90 M(+4.3%) |
| June 2012 | - | -$259.66 M(+3.1%) |
| Mar 2012 | - | -$251.77 M(+3.8%) |
| Dec 2011 | -$242.45 M(+15.5%) | -$242.45 M(+2.9%) |
| Sept 2011 | - | -$235.54 M(+3.7%) |
| June 2011 | - | -$227.21 M(+2.3%) |
| Mar 2011 | - | -$222.07 M(+5.7%) |
| Dec 2010 | -$210.00 M(+15.1%) | -$210.00 M(+4.6%) |
| Sept 2010 | - | -$200.75 M(+5.5%) |
| June 2010 | - | -$190.33 M(+2.9%) |
| Mar 2010 | - | -$184.95 M(+1.3%) |
| Dec 2009 | -$182.50 M(+12.5%) | -$182.50 M(+5.5%) |
| Sept 2009 | - | -$173.01 M(+4.1%) |
| June 2009 | - | -$166.21 M(+0.5%) |
| Mar 2009 | - | -$165.39 M(+2.0%) |
| Dec 2008 | -$162.17 M(+22.7%) | -$162.17 M(+4.2%) |
| Sept 2008 | - | -$155.64 M(+4.6%) |
| June 2008 | - | -$148.82 M(+6.0%) |
| Mar 2008 | - | -$140.41 M(+6.3%) |
| Dec 2007 | -$132.13 M(+27.7%) | -$132.13 M(+8.8%) |
| Sept 2007 | - | -$121.45 M(+4.6%) |
| June 2007 | - | -$116.13 M(+3.6%) |
| Mar 2007 | - | -$112.13 M(+8.4%) |
| Dec 2006 | -$103.46 M(+32.6%) | -$103.46 M(+1.9%) |
| Sept 2006 | - | -$101.55 M(+9.4%) |
| June 2006 | - | -$92.78 M(+8.6%) |
| Mar 2006 | - | -$85.47 M(+9.6%) |
| Dec 2005 | -$78.01 M(+51.6%) | -$78.01 M(+22.6%) |
| Sept 2005 | - | -$63.65 M(+3.7%) |
| June 2005 | - | -$61.36 M(+9.6%) |
| Mar 2005 | - | -$56.00 M(+8.8%) |
| Dec 2004 | -$51.48 M(+4.2%) | -$51.48 M(+9.2%) |
| Sept 2004 | - | -$47.16 M(-8.8%) |
| June 2004 | - | -$51.70 M(+8.0%) |
| Mar 2004 | - | -$47.90 M(-3.0%) |
| Dec 2003 | -$49.38 M(+23.1%) | -$49.38 M(+2.4%) |
| Sept 2003 | - | -$48.24 M(+6.2%) |
| June 2003 | - | -$45.44 M(+4.7%) |
| Mar 2003 | - | -$43.38 M(+8.2%) |
| Dec 2002 | -$40.10 M(+48.0%) | -$40.10 M(+15.9%) |
| Sept 2002 | - | -$34.60 M(+9.4%) |
| June 2002 | - | -$31.64 M(+5.3%) |
| Mar 2002 | - | -$30.03 M(+10.8%) |
| Dec 2001 | -$27.10 M(+70.5%) | -$27.10 M(+12.1%) |
| Sept 2001 | - | -$24.18 M(+12.8%) |
| June 2001 | - | -$21.45 M |
| Dec 2000 | -$15.89 M | - |
FAQ
- What is Plus Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Plus Therapeutics?
- What is Plus Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Plus Therapeutics?
- What is Plus Therapeutics quarterly retained earnings year-on-year change?
What is Plus Therapeutics annual retained earnings?
The current annual retained earnings of PSTV is -$480.50 M
What is the all time high annual retained earnings for Plus Therapeutics?
Plus Therapeutics all-time high annual retained earnings is -$15.89 M
What is Plus Therapeutics quarterly retained earnings?
The current quarterly retained earnings of PSTV is -$489.58 M
What is the all time high quarterly retained earnings for Plus Therapeutics?
Plus Therapeutics all-time high quarterly retained earnings is -$21.45 M
What is Plus Therapeutics quarterly retained earnings year-on-year change?
Over the past year, PSTV quarterly retained earnings has changed by -$9.07 M (-1.89%)